MCCN.V - Medcolcanna Organics Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.1150
-0.0100 (-8.00%)
At close: 2:47PM EDT
Stock chart is not supported by your current browser
Previous Close0.1250
Open0.1150
Bid0.1150 x N/A
Ask0.1300 x N/A
Day's Range0.1150 - 0.1150
52 Week Range0.1100 - 0.2950
Volume1,000
Avg. Volume45,447
Market Cap9.85M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    View from the C-Suite: Felipe de la Vega, Chief Executive Officer, Medcolcanna Organics Inc., tells his company's story. Filmed on September 5, 2019

    View from the C-Suite: Felipe de la Vega, Chief Executive Officer, Medcolcanna Organics Inc., tells his company's story. Filmed on September 5, 2019

  • GlobeNewswire

    Medcolcanna Organics Inc. Announces Financial Results for Second Quarter of 2019

    Medcolcanna Organics Inc. (the “Company” or “Medcolcanna”) (MCCN.V) announces the filing of its financial and operating results for the three and six months ended June 30, 2019. All dollar values in this news release and the Company’s financial disclosures are in Canadian dollars, unless otherwise stated. Completed the quarter with a $6.4 million cash balance and was able to reduce its capital expenditure budget by $1.5 million.

  • Do Institutions Own Medcolcanna Organics Inc. (CVE:MCCN) Shares?
    Simply Wall St.

    Do Institutions Own Medcolcanna Organics Inc. (CVE:MCCN) Shares?

    If you want to know who really controls Medcolcanna Organics Inc. (CVE:MCCN), then you'll have to look at the makeup...

  • GlobeNewswire

    Medcolcanna Signs Licensing and Profit-Sharing Agreement with Herbolea Biotech for Patent Pending Technology

    BOGOTÁ, Colombia, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc. (MCCN.V) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that it has signed a Licensing and Processing Services Agreement with Herbolea Biotech S.r.l. With the closing of these two agreements, Medcolcanna will have the license rights to use Bio-HerbolysisTM for their extraction requirements, as well as offer processing services to third parties in Colombia, delivering full spectrum oil, distillates and crystals.

  • GlobeNewswire

    Medcolcanna Signs Letter of Intent with Top Medical Center and Completes Purchase of Innovative CBD Products

    BOGOTÁ, Colombia, July 25, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc. (MCCN.V) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that it has signed a Letter of Intent (“LOI”) with the University Medical Center Groningen (“UMCG”). “We are extremely honoured to have been chosen by the University Medical Center Groningen, a top 100 ranked university in the world, to conduct several research studies on the effects of various formulations of cannabinoids,” commented Felipe de la Vega, CEO of Medcolcanna.

  • GlobeNewswire

    Medcolcanna Strengthens Board of Directors with Addition of Pharmaceutical Executive

    BOGOTÁ, Colombia, June 11, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc. (MCCN.V) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce the appointment of Mr. José Joaquin Mora Hernandez to its Board of Directors as well as company advisor. “We are very pleased to welcome Mr. Mora Hernandez to our Board of Directors,” said Felipe de la Vega, Medcolcanna’s CEO.

  • GlobeNewswire

    Medcolcanna Enters Agreement to Acquire Interest in Cannabis Oil Refinery

    BOGOTÁ, Colombia, May 30, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc. (MCCN.V) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is excited to announce that it has entered into a Master Agreement (the “Agreement”) with Greenstein Capital Ltd. (“GCL”), a Maltese company. GCL’s subsidiary (“RefineryCo”) plans to construct and operate a refinery (the “Refinery”) in Germany for cannabis oil derivatives.

  • GlobeNewswire

    Medcolcanna Announces Commencement of Trading on the TSX Venture Exchange Under the Symbol MCCN and Other Corporate Matters

    BOGOTÁ, Colombia, May 23, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a medical cannabis company operating in Colombia, is pleased to announce that its shares will begin trading on the TSX Venture Exchange (the “Exchange”) under the symbol “MCCN” today. “This listing represents a significant step forward for us and demonstrates our ability to execute on our business plan designed to make Medcolcanna a global leader in the cultivation, production and distribution of quality medical cannabis and cannabis related products,” stated Felipe de la Vega, Medcolcanna’s CEO. The Company is also pleased to announce that it has entered into an agreement for the purchase of Innovative CBD Products B.V. (“ICP”), a Netherlands-based company, from Harm Hids, a Dutch citizen and resident (“Seller”).